Newsletter | August 27, 2024

08.27.24 -- Stem Cells, Machine Learning, And Laser Optics In Regenerative Medicine

SPONSOR

Don't miss the next Cell & Gene Live discussion on how CAR-T manufacturing has advanced recently and where it's going. Host Tyler Menichiello welcomes CTMC's Jason Bock, Ph.D., Cartesian Therapeutics' Emily English, Ph.D., and former FDA-turned Dark Horse consultant and CMC Expert, Tal Salz, Ph.D., for this digital event happening Tuesday, August 27, at 11 AM ET. Registration is free thanks to the support of CPC.

FROM THE EDITOR

Stem Cells, Machine Learning, And Laser Optics In Regenerative Medicine

Cellino Biotech's CEO, Nabiha Saklayen, Ph.D., explains how the company plans to make personalized regenerative medicines viable at large scale for the first time.

INDUSTRY INSIGHTS

Remote Regulatory Assessments Q&A

Explore what Remote Regulatory Assessments (RRAs) are and how updated guidance on these examinations could help clarify the consequences of non-compliance.

8 Tips To Improve Compensation In Multicolor Flow Experiments

Flow cytometry compensation is critical, for it directly impacts data accuracy and quality. Here, we share eight tips to improve compensation in multicolor flow experiments.

Keeping Up With Advancements In Cell And Gene Therapies

Many patients are seeing cell or gene therapy treatments for their disease entering clinical trials. Review these rapidly changing advanced therapies and the post-pandemic pressures they face.

How Does The Australian Advantage Maximize Benefits For US Biotechs?

The "Australian Advantage" approach offers US biotech firms numerous benefits, including a cash rebate of almost 50%, faster timelines, no IND requirement, and globally accepted data.

Advances In Bioprocessing For Biologics And Gene Therapy Vectors

This article collection highlights the importance of continued research and development in the field of bioprocessing to revolutionize the next generation of therapies and personalized medicine.

Elevating Quality Beyond Compliance

See how one company was able to connect its quality processes, improve collaboration across business functions, and address the needs of its digitally-aware workforce.

Reliably Generate iNKs With A Feeder Free Differentiation Process

Discover how human iPSCs-derived NKs (iNKs) can provide a uniform and potentially unlimited source of NKs for allogeneic cell therapy, allowing NKs to expand more easily to clinically relevant numbers.

A Step-By-Step Guide To Cell Banking

Cell banking stands at the forefront of medical advancement. This guide delves into the steps involved in protecting these priceless resources, from cell collection and processing to storage and cell expansion.

High Yield Protein Production System For Suspension CHO Cells

Reduced the risk of contamination caused by repeated handling of the culture during transient protein production in suspension CHO cells.

Embarking On A Successful Cleanroom Project: Conception To Delivery

Learn how you can obtain comprehensive solutions for cleanroom projects that help you ensure regulatory compliance and operational efficiency.

Maximizing The Potential Of Cell Therapy Products

Consider a variety of all-in-one, ready-to-use, chemically-defined, and animal-component-free cryopreservation solutions for overcoming the challenges of shipping cell therapy products.

SOLUTIONS

New To mRNA Manufacturing? Considerations For Starting

Help Bring Your Breakthrough Cancer Treatments To Market Faster

Trust Us To Manage Your Virtual Clinical Trial

From Concept To Creation: An Inside Look At Engineering Design

Low Endotoxin Products For Critical Environments

Connect With Cell & Gene: